EGF and cancer: Moreover, the ability of EGF to enhance cell migration in serum-free media was observed only in DUOX1-deficient cells (Fig. 2f, and Supplemental Fig. 5), consistent with previous findings linking DUOX1 silencing to increased epithelial-to-mesenchymal transition and cancer cell invasiveness9.